First Sponsor (ADN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
29 Oct, 2026Executive summary
PRC development presales remained subdued in 1Q2025 amid weak sentiment; all ongoing PRC projects under construction are expected to complete in 2025, with handovers underway at completed phases.
European property operating income was €7.8m, broadly stable YoY despite major refurbishment at Le Méridien Frankfurt; excluding that hotel, income rose 7.2% to €8.4m.
A settlement was reached on the RMB375.8m defaulted loan; RMB165.3m was received on 9 April 2025, leaving RMB232.2m principal due by 6 June 2025.
Financial highlights
European property portfolio operating income was €7.839m in 1Q2025 versus €7.874m in 1Q2024; Dutch office income rose 1.9% to €5.981m, while European hotel income fell 7.4% to €1.858m.
European hotels revenue was €23.40m, down 3.2% YoY; EBITDA was €0.72m versus €0.91m, down 20.9%. Excluding Le Méridien Frankfurt, revenue rose 2.5% and EBITDA was €1.3m, up 48.4%.
Chengdu Wenjiang hotels revenue fell 14.0% to RMB15.57m, while EBITDA increased to RMB2.34m from RMB1.55m, supported by lower maintenance and owner expenses.
Outlook and guidance
Further PRC government stimulus and support expected in 2025 may contribute to a gradual market recovery; pricing strategy continues to avoid deep discounts.
Completion targets include PRC projects in 2025, Puccini Hotel Milan and Le Méridien Frankfurt in 4Q2025, and Sydney House in 3Q2027; Meerparc redevelopment is scheduled to begin in 2H2026.
The Fenggang residential land public tender is expected in 2H2026; final loan settlement payment of RMB232.2m plus default interest is due no later than 6 June 2025.
Latest events from First Sponsor
- European income grew as PRC presales stayed weak; NSI profit and S$244m rights proceeds bolstered 3Q.ADN
Q3 2024 TU - FY2023 profit fell 90.5% as European property income and equity proceeds supported resilience.ADN
H2 2023 - European income and hotel earnings improved as PRC property demand stayed weak.ADN
Q1 2024 TU - Revenue rose 27.2% and profit 12.4%, despite weak PRC pre-sales and higher financing costs.ADN
H1 2024 - NSI earnings lifted FY2024 profit despite PRC weakness and impairment charges.ADN
H2 2024 - Attributable profit rose 59.2% despite lower revenue and subdued PRC pre-sales.ADN
H1 2025 - Loan recovery and refinancing bolster flexibility as PRC sales stay weak and European income edges higher.ADN
Q3 2025 TU - Derivative losses drove FY2025 reported loss despite adjusted profit and stronger European hotels.ADN
H2 2025 - H1 attributable loss reached S$92.8m as derivatives and Humen impairment offset European NOI growth.ADN
H1 2026